Patents by Inventor Remy Poupot

Remy Poupot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DENDRIMERS HAVING THIOPHOSPHORAMIDATE PATTERNS AND DERIVATIVES
    Publication number: 20240116963
    Abstract: The present invention relates to new dendrimers with thiophosphoramidate units and derivatives, their preparation method and their use.
    Type: Application
    Filed: December 22, 2020
    Publication date: April 11, 2024
    Inventors: Abdelouahd OUKHRIB, Julien AUJARD-CATOT, Rèmy POUPOT, Cèdric-Olivier TURRIN
  • ANTI-INFLAMMATORY DENDRIMER FORMULATION FOR THE TREATMENT OF PSORIASIS
    Publication number: 20230085651
    Abstract: The present invention relates to sugar-derived catanionic surfactant vesicles comprising anti-inflammatory dendrimers and to their use as a medicament, more particularly in the treatment of psoriasis.
    Type: Application
    Filed: December 22, 2020
    Publication date: March 23, 2023
    Inventors: Muriel BLANZAT, Ranime JEBBAWI, Rémy POUPOT, Cédric-Olivier TURRIN, Michel SIMON, Emily CLEMENT, Hélène LABIE, Abdelouahd OUKHRIB
  • Phosphorylated dendrimers as antiinflammatory drugs
    Patent number: 10106565
    Abstract: Dendrimers with monophosphonic or bisphosphonic terminations for the treatment of inflammatory diseases.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: October 23, 2018
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PAUL SABATIER (TOULOUSE III)
    Inventors: Mary Poupot, Remy Poupot, Jean-Jacques Fournie, Damien Portevin, Severine Fruchon, Jean-Luc Davignon, Cedric-Olivier Turrin, Anne-Marie Caminade, Jean-Pierre Majoral, Olivier Rolland
  • Use of dendrimers to stimulate cell growth
    Patent number: 8815834
    Abstract: The present invention relates to the use of dendrimers with monophosphonic or bisphosphonic terminations in order to stimulate the growth of cell cultures or to activate cells in culture.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: August 26, 2014
    Assignees: Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Rhodia UK Limited
    Inventors: Jean-Pierre Majoral, Anne-Marie Jeannine Jacqueline Caminade, Jean-Jacques Fournie, Laurent Griffe, Mary Poupot-Marsan, Rémy Poupot, Cédric-Olivier Turrin
  • PHOSPHORYLATED DENDRIMERS AS ANTIINFLAMMATORY DRUGS
    Publication number: 20130336997
    Abstract: Dendrimers with monophosphonic or bisphosphonic terminations for the treatment of inflammatory diseases.
    Type: Application
    Filed: July 1, 2013
    Publication date: December 19, 2013
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Mary POUPOT, Remy POUPOT, Jean-Jacques FOURNIE, Damien PORTEVIN, Severine FRUCHON, Jean-Luc DAVIGNON, Cedric-Olivier DAVIGNON, Anne-Marie CAMINADE, Jean-Pierre MAJORAL, Oliver ROLLAND
  • PHOSPHORYLATED DENDRIMERS AS ANTIINFLAMMATORY DRUGS
    Publication number: 20100173871
    Abstract: A method for treating inflammatory diseases through an anti-inflammatory type activation of monocytes, the method includes the administration to a patient in need thereof of an effective quantity of at least one dendrimer with mono- or biphosphonic terminations.
    Type: Application
    Filed: August 1, 2008
    Publication date: July 8, 2010
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Mary Poupot, Remy Poupot, Jean-Jacques Fournie, Damien Portevin, Severine Fruchon, Jean-Luc Davignon, Cedric-Olivier Davignon, Anne-Marie Caminade, Jean-Pierre Majoral, Oliver Rolland
  • Use of Dendrimers to Stimulate Cell Growth
    Publication number: 20090142316
    Abstract: The present invention relates to the use of dendrimers with monophosphonic or bisphosphonic terminations in order to stimulate the growth of cell cultures or to activate cells in culture.
    Type: Application
    Filed: July 29, 2005
    Publication date: June 4, 2009
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M, RHODIA UK LIMITED
    Inventors: Jean-Pierre Majoral, Anne-Marie Jeannine Jacqueline Caminade, Jean-Jacques Fournie, Laurent Griffe, Mary Poupot-Marsan, Remy Poupot, Cedric-Olivier Turrin